Cargando…

Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis

BACKGROUND AND PURPOSE: Natural killer (NK) cells may play a role in multiple sclerosis (MS). Ratios of NK cells to CD4(+) T cells have been proposed as a biomarker for the therapeutic effect of stem cell transplantation in MS. The objectives here were to explore the relevance of this ratio in MS pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimpen, Max, Muris, Anne‐Hilde, Rolf, Linda, Gerlach, Oliver, Kuhle, Jens, Hupperts, Raymond, Smolders, Joost, Damoiseaux, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898592/
https://www.ncbi.nlm.nih.gov/pubmed/33326677
http://dx.doi.org/10.1111/ene.14680
_version_ 1783653893835587584
author Mimpen, Max
Muris, Anne‐Hilde
Rolf, Linda
Gerlach, Oliver
Kuhle, Jens
Hupperts, Raymond
Smolders, Joost
Damoiseaux, Jan
author_facet Mimpen, Max
Muris, Anne‐Hilde
Rolf, Linda
Gerlach, Oliver
Kuhle, Jens
Hupperts, Raymond
Smolders, Joost
Damoiseaux, Jan
author_sort Mimpen, Max
collection PubMed
description BACKGROUND AND PURPOSE: Natural killer (NK) cells may play a role in multiple sclerosis (MS). Ratios of NK cells to CD4(+) T cells have been proposed as a biomarker for the therapeutic effect of stem cell transplantation in MS. The objectives here were to explore the relevance of this ratio in MS patients by analysing NK and T cell subsets, as well as their prognostic value for disease activity. METHODS: Baseline peripheral blood mononuclear cells of 50 relapsing–remitting MS patients, participating in our vitamin D supplementation study (SOLARIUM), were analysed with flow cytometry. Disease activity was measured as new magnetic resonance imaging lesions, relapses and mean plasma neurofilament light chain levels after 48 weeks of follow‐up. RESULTS: The proportion of NK cells correlated negatively with CD4(+) T cells (R = −0.335, p = 0.001) and interleukin 17A (IL‐17A(+)) CD4(+) T cells (R = −0.203, p = 0.043). Participants with magnetic resonance imaging activity or relapses displayed lower NK/IL‐17A(+ )CD4(+) T cell ratios (p =0.025 and p = 0.006, respectively). The NK/IL‐17A(+ )CD4(+) T cell ratio correlated negatively with neurofilament light chain levels (R = −0.320, p = 0.050). Vitamin D supplementation did not affect these ratios. CONCLUSIONS: Our data suggest a protective role of an expanded NK cell compartment compared to the CD4(+) T cell subset fractions in relapsing–remitting MS patients. NK/CD4(+) T cell ratios may be a prognostic biomarker for disease activity in MS.
format Online
Article
Text
id pubmed-7898592
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78985922021-03-03 Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis Mimpen, Max Muris, Anne‐Hilde Rolf, Linda Gerlach, Oliver Kuhle, Jens Hupperts, Raymond Smolders, Joost Damoiseaux, Jan Eur J Neurol Multiple Sclerosis BACKGROUND AND PURPOSE: Natural killer (NK) cells may play a role in multiple sclerosis (MS). Ratios of NK cells to CD4(+) T cells have been proposed as a biomarker for the therapeutic effect of stem cell transplantation in MS. The objectives here were to explore the relevance of this ratio in MS patients by analysing NK and T cell subsets, as well as their prognostic value for disease activity. METHODS: Baseline peripheral blood mononuclear cells of 50 relapsing–remitting MS patients, participating in our vitamin D supplementation study (SOLARIUM), were analysed with flow cytometry. Disease activity was measured as new magnetic resonance imaging lesions, relapses and mean plasma neurofilament light chain levels after 48 weeks of follow‐up. RESULTS: The proportion of NK cells correlated negatively with CD4(+) T cells (R = −0.335, p = 0.001) and interleukin 17A (IL‐17A(+)) CD4(+) T cells (R = −0.203, p = 0.043). Participants with magnetic resonance imaging activity or relapses displayed lower NK/IL‐17A(+ )CD4(+) T cell ratios (p =0.025 and p = 0.006, respectively). The NK/IL‐17A(+ )CD4(+) T cell ratio correlated negatively with neurofilament light chain levels (R = −0.320, p = 0.050). Vitamin D supplementation did not affect these ratios. CONCLUSIONS: Our data suggest a protective role of an expanded NK cell compartment compared to the CD4(+) T cell subset fractions in relapsing–remitting MS patients. NK/CD4(+) T cell ratios may be a prognostic biomarker for disease activity in MS. John Wiley and Sons Inc. 2020-12-30 2021-03 /pmc/articles/PMC7898592/ /pubmed/33326677 http://dx.doi.org/10.1111/ene.14680 Text en © 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Multiple Sclerosis
Mimpen, Max
Muris, Anne‐Hilde
Rolf, Linda
Gerlach, Oliver
Kuhle, Jens
Hupperts, Raymond
Smolders, Joost
Damoiseaux, Jan
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title_full Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title_fullStr Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title_full_unstemmed Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title_short Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
title_sort prognostic value of natural killer cell/t cell ratios for disease activity in multiple sclerosis
topic Multiple Sclerosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898592/
https://www.ncbi.nlm.nih.gov/pubmed/33326677
http://dx.doi.org/10.1111/ene.14680
work_keys_str_mv AT mimpenmax prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT murisannehilde prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT rolflinda prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT gerlacholiver prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT kuhlejens prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT huppertsraymond prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT smoldersjoost prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis
AT damoiseauxjan prognosticvalueofnaturalkillercelltcellratiosfordiseaseactivityinmultiplesclerosis